Stem cell therapies for recessive dystrophic epidermolysis bullosa.

scientific article

Stem cell therapies for recessive dystrophic epidermolysis bullosa. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1365-2133.2010.09981.X
P698PubMed publication ID20716209

P50authorDusko IlicQ56768774
John McgrathQ72104357
P2093author name stringA Petrova
P2860cites workDisease-specific induced pluripotent stem cellsQ24641981
Virus-free induction of pluripotency and subsequent excision of reprogramming factorsQ24644686
Induction of pluripotent stem cells from adult human fibroblasts by defined factorsQ27860967
Embryonic stem cell lines derived from human blastocystsQ27861010
Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factorsQ28749672
Induced pluripotent stem cells from a spinal muscular atrophy patientQ29614340
Efficient and rapid generation of induced pluripotent stem cells from human keratinocytesQ29614341
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblastsQ29614794
Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2Q29617098
piggyBac transposition reprograms fibroblasts to induced pluripotent stem cellsQ29619409
Generation of human induced pluripotent stem cells from dermal fibroblastsQ34588555
Multipotent hair follicle stem cells promote repair of spinal cord injury and recovery of walking functionQ46078284
Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell typeQ47933679
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectrecessive dystrophic epidermolysis bullosaQ7302398
P304page(s)1149-1156
P577publication date2010-11-04
P1433published inBritish Journal of DermatologyQ4970191
P1476titleStem cell therapies for recessive dystrophic epidermolysis bullosa
P478volume163

Reverse relations

cites work (P2860)
Q37649276Allogeneic blood and bone marrow cells for the treatment of severe epidermolysis bullosa: repair of the extracellular matrix
Q37873887Concise review: Transplantation of human hematopoietic cells for extracellular matrix protein deficiency in epidermolysis bullosa
Q45871193Correction of dog dystrophic epidermolysis bullosa by transplantation of genetically modified epidermal autografts
Q38695955Human amniotic membrane grafts in therapy of chronic non-healing wounds
Q53143040Management of severe epidermolysis bullosa by haematopoietic transplant: principles, perspectives and pitfalls.
Q26865551Molecular therapeutics for heritable skin diseases
Q36610899Novel molecular therapies for heritable skin disorders
Q37707008Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa
Q38510204Recessive dystrophic epidermolysis bullosa: a review of disease pathogenesis and update on future therapies.
Q38692453Somatic correction of junctional epidermolysis bullosa by a highly recombinogenic AAV variant.

Search more.